EPM2A

Alternative Names

Laforin isoform a,epilepsy, progressive myoclonus type 2A Lafora disease (laforin), epilepsy progressive myoclonus type 2 Lafora disease (laforin), LDE, LD
Product Type

Monoclonal Antibody
NCBI Number

NP_005661
Concentration

1mg/ml
Formulation

Liquid. In Phosphate-Buffered Saline (pH 7.4) with 0.02% Sodium Azide, 10% Glycerol.
Immunogen

Recombinant human EPM2A (243-331aa) purified from E. coli
Applications

ELISA,WB,ICC/IF
Reacts With

Human
Clone

k2A3
Usage

The antibody has been tested by ELISA and Western blot analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results. Recommended dilution range for Western blot analysis is 1:1,000 ~ 2,000. Recommended starting dilution is 1:1,000.
Antigen Species

Human
UniProt No

O95278
Gene Category

Enzymes & Proteases
Conjugation

Unconjugated
Clonality

Monoclonal
Ab Purification Comment

By protein-G affinity chromatography
Storage and shipping

Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
Data sheet
Note

This product is available in other size, please contact us for more details

Identity

HGNC:3413
Gene

EPM2A
Long gene name

EPM2A glucan phosphatase, laforin
Synonyms gene name
- epilepsy, progressive myoclonus type 2, Lafora disease (laforin)
- epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
- EPM2A, laforin glucan phosphatase
Synonyms
- LDE
- LD
GenBank acession
- AF284580
Locus

6q24.3
Discovery year

1998-10-01
Entrez gene record

7957
Pubmed identfication
- 9222970
- 7485240
Classification
- Atypical dual specificity phosphatases
VEGA ID

OTTHUMG00000015747